Home   »   News   »   Member News & Releases
Share +
10.26.2018 | Member News & Releases

CACTUS appoints Head of China Operations

October 26, 2018 – Beijing, China – Editage, the flagship business unit of Cactus Communications, has appointed Frank Xu as the Managing Director of China Operations. China is the world’s largest producer of research output in English and, as Managing Director, Xu is expected to drive the future growth and strategy of the group. Xu has over 17 years of experience in scholarly and educational publishing. 

Commenting on his appointment, Mr. Xu says, “Editage has a deserved global reputation as an academic editing and author service provider with a unique business model. I am excited to be on board and look forward to working with the team.”

“Frank’s previous experience, extensive knowledge of the Chinese scholarly publishing market, and vast experience in scientific publishing and education are second to none; we are thrilled to have him on board,” said Abhishek Goel, Co-founder and CEO, Cactus Communications.

Frank was previously the Director of Open Research for Springer Nature Greater China; he was responsible for its open access business in the region and handled marketing, institutional partnerships, thought leadership building, and the OA journal partnership program under Nature Research, BMC, and the Springer Open platform. He was Macmillan China’s first full-time employee and has also served as its Director of Institutional Sales, prior to its merger with Springer.

Frank holds an MBA from the Sorbonne Graduate Business School of University Paris 1 Pantheon, France.

About Cactus Communications – Founded in 2002, Cactus Communications is a global scholarly and medical communications company with offices in Tokyo, Seoul, Shanghai, Beijing, London, New Jersey, Mumbai, and Singapore. CACTUS operates through two main verticals: Editage, a leading consumer technology business that provides editorial, translation, and digital solutions, and Cactus Life Sciences, which provides rich strategic and tactical content solutions to stakeholders associated with global pharma and device-making. The team, comprising over 750 full-time employees and 2,500 freelancers, has served close to 200,000 researchers, doctors, and scientists across 173 countries and has transformed over 900,000 papers across 1,200 disciplines.

View Comments

Be the first to write a comment!

Join the Conversation

Your email address will not be published. Required fields are marked *